Pacira BioSciences, Inc. (PCRX) — Capital Reinvestment Ratio
Latest as of March 2026:
0.11x
Pacira BioSciences, Inc. (PCRX) has a Capital Reinvestment Ratio of 0.11x as of March 2026, meaning it reinvests 0% of its operating cash flow ($25.68 Million) in capital expenditures ($2.72 Million). See PCRX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
$25.68 Million
USD
Capital Expenditures
$2.72 Million
USD
Data as of
Mar 2026
Most recent filing
Pacira BioSciences, Inc. Capital Reinvestment Ratio (2014–2025)
This chart tracks Pacira BioSciences, Inc.'s Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Pacira BioSciences, Inc. (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pacira BioSciences, Inc. from 2014 to 2025. For live market cap and broader valuation context, see Pacira BioSciences, Inc. stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $151.99 Million | $15.33 Million | ▲ +79.6% |
| 2024 | 0.06x | $189.39 Million | $10.64 Million | ▼ -42.7% |
| 2023 | 0.10x | $154.65 Million | $15.16 Million | ▼ -52.6% |
| 2022 | 0.21x | $145.27 Million | $30.08 Million | ▼ -43.3% |
| 2021 | 0.36x | $125.72 Million | $45.87 Million | ▼ -25.7% |
| 2020 | 0.49x | $77.03 Million | $37.80 Million | ▲ +240.6% |
| 2019 | 0.14x | $70.52 Million | $10.16 Million | ▼ -51.5% |
| 2018 | 0.30x | $48.87 Million | $14.51 Million | ▼ -72.6% |
| 2017 | 1.08x | $17.79 Million | $19.27 Million | ▲ +46.7% |
| 2016 | 0.74x | $33.45 Million | $24.71 Million | ▼ -48.1% |
| 2015 | 1.42x | $29.00 Million | $41.27 Million | ▲ +65.6% |
| 2014 | 0.86x | $25.47 Million | $21.89 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow